Cell-Cycle Reprogramming for PI3K Inhibition Overrides a Relapse-Specific C481S <i>BTK</i> Mutation Revealed by Longitudinal Functional Genomics in Mantle Cell Lymphoma
David Chiron(Centre National de la Recherche Scientifique), Selina Chen‐Kiang(NewYork–Presbyterian Hospital), Amy J. Johnson(Ouranos), Ken Eng(Cornell University), John P. Leonard(New York University), Peter Martin(Northwestern University), Pedro Blecua(Cornell University), Olivier Elemento(Cornell University), Betty Chang(Rigel (United States)), Priyanka Vijay(Cornell University), Xiangao Huang(Cornell University), Scott Ely(NewYork–Presbyterian Hospital), Christopher E. Mason(Cornell University), Siraj M. Ali(UPMC Hillman Cancer Center), Susan Mathew(NewYork–Presbyterian Hospital), Maurizio Di Liberto(Howard Hughes Medical Institute), Jeff P. Sharman(Willamette Valley Cancer Institute and Research Center)
Cited by 272
Related Papers
methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles
|Genome biology|2012|2.4k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2013|1.7k